T. Rowe Price Associates’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324M | Sell |
1,875,491
-380,611
| -17% | -$65.7M | 0.04% | 336 |
|
|
2025
Q1 | $352M | Sell |
2,256,102
-27,105
| -1% | -$4.22M | 0.04% | 321 |
|
|
2024
Q4 | $314M | Buy |
2,283,207
+162,079
| +8% | +$22.3M | 0.04% | 343 |
|
|
2024
Q3 | $317M | Buy |
2,121,128
+336,980
| +19% | +$50.3M | 0.04% | 350 |
|
|
2024
Q2 | $243M | Buy |
1,784,148
+2,222
| +0.1% | +$303K | 0.03% | 383 |
|
|
2024
Q1 | $269M | Buy |
1,781,926
+336,976
| +23% | +$50.9M | 0.03% | 371 |
|
|
2023
Q4 | $182M | Sell |
1,444,950
-192,898
| -12% | -$24.3M | 0.02% | 429 |
|
|
2023
Q3 | $153M | Sell |
1,637,848
-419,316
| -20% | -$39.3M | 0.02% | 440 |
|
|
2023
Q2 | $184M | Sell |
2,057,164
-1,312,779
| -39% | -$117M | 0.03% | 403 |
|
|
2023
Q1 | $361M | Sell |
3,369,943
-339,898
| -9% | -$36.4M | 0.05% | 287 |
|
|
2022
Q4 | $453M | Sell |
3,709,841
-165,022
| -4% | -$20.2M | 0.07% | 250 |
|
|
2022
Q3 | $400M | Sell |
3,874,863
-1,290,512
| -25% | -$133M | 0.07% | 255 |
|
|
2022
Q2 | $480M | Buy |
5,165,375
+295,224
| +6% | +$27.4M | 0.06% | 297 |
|
|
2022
Q1 | $572M | Buy |
4,870,151
+108,958
| +2% | +$12.8M | 0.06% | 304 |
|
|
2021
Q4 | $641M | Sell |
4,761,193
-74,521
| -2% | -$10M | 0.06% | 305 |
|
|
2021
Q3 | $771M | Sell |
4,835,714
-225,540
| -4% | -$35.9M | 0.07% | 268 |
|
|
2021
Q2 | $666M | Sell |
5,061,254
-12,082
| -0.2% | -$1.59M | 0.06% | 295 |
|
|
2021
Q1 | $654M | Sell |
5,073,336
-1,545,706
| -23% | -$199M | 0.07% | 293 |
|
|
2020
Q4 | $1.1B | Sell |
6,619,042
-158,593
| -2% | -$26.5M | 0.11% | 193 |
|
|
2020
Q3 | $1.05B | Sell |
6,777,635
-286,749
| -4% | -$44.3M | 0.12% | 180 |
|
|
2020
Q2 | $1.04B | Sell |
7,064,384
-128,445
| -2% | -$19M | 0.13% | 162 |
|
|
2020
Q1 | $810M | Sell |
7,192,829
-568,467
| -7% | -$64M | 0.13% | 167 |
|
|
2019
Q4 | $1.08B | Sell |
7,761,296
-13,696
| -0.2% | -$1.91M | 0.14% | 152 |
|
|
2019
Q3 | $749M | Buy |
7,774,992
+596,956
| +8% | +$57.5M | 0.11% | 208 |
|
|
2019
Q2 | $827M | Buy |
7,178,036
+2,509,034
| +54% | +$289M | 0.12% | 194 |
|
|
2019
Q1 | $550M | Buy |
4,669,002
+558,110
| +14% | +$65.7M | 0.08% | 242 |
|
|
2018
Q4 | $258M | Buy |
4,110,892
+729,096
| +22% | +$45.7M | 0.04% | 368 |
|
|
2018
Q3 | $240M | Buy |
3,381,796
+282,697
| +9% | +$20M | 0.04% | 438 |
|
|
2018
Q2 | $206M | Buy |
3,099,099
+281,261
| +10% | +$18.7M | 0.03% | 475 |
|
|
2018
Q1 | $184M | Buy |
2,817,838
+2,363,868
| +521% | +$155M | 0.03% | 482 |
|
|
2017
Q4 | $18.2M | Buy |
+453,970
| New | +$18.2M | ﹤0.01% | 1212 |
|